Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Vekemans

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
The Lancet. Infectious Diseases|July 11, 2016
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trialLucas Otieno, Martina Oneko, Walter Otieno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?Joy E Lawn, Fiorella Bianchi-Jassir, Neal J Russell, et al.
Lancet (London, England)|December 7, 2019
The complex challenges of HIV vaccine development require renewed and expanded global commitmentLinda-Gail Bekker, Roger Tatoud, Francois Dabis, et al.
Human Vaccines & Immunotherapeutics|April 10, 2018
Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trialInnocent Valéa, Samuel Adjei, Effua Usuf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and ChildrenAnna C Seale, Fiorella Bianchi-Jassir, Neal J Russell, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analysesMaya Kohli-Lynch, Neal J Russell, Anna C Seale, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
The Lancet. Infectious Diseases|July 11, 2016
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trialLucas Otieno, Martina Oneko, Walter Otieno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?Joy E Lawn, Fiorella Bianchi-Jassir, Neal J Russell, et al.
Lancet (London, England)|December 7, 2019
The complex challenges of HIV vaccine development require renewed and expanded global commitmentLinda-Gail Bekker, Roger Tatoud, Francois Dabis, et al.
Human Vaccines & Immunotherapeutics|April 10, 2018
Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trialInnocent Valéa, Samuel Adjei, Effua Usuf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and ChildrenAnna C Seale, Fiorella Bianchi-Jassir, Neal J Russell, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2017
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analysesMaya Kohli-Lynch, Neal J Russell, Anna C Seale, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Pageof 12